American Hospital Dubai partnered with Abbott to introduce advanced early cancer detection technology in the UAE. It is the first private hospital in Dubai to offer this next-generation screening solution. The move aims to support the UAE's efforts to improve early diagnosis and strengthen cancer care.
The purpose of the Memorandum of Understanding (MoU) is to use advanced technology that can detect cancers in early stages. Early detection enables patients to receive treatments earlier.
According to American Hospital Dubai, the use of advanced technology will help the hospital deliver better diagnostic services in addition to supporting the healthcare goals of the UAE. It is famous for its advanced medical treatment and diagnostic services. Abbott is a major international healthcare organization specializing in diagnostics, medical devices, nutrition, and pharmaceuticals.
It also illustrates the trend towards early detection of diseases in the healthcare industry. Hospitals are incorporating new technologies into their systems to enhance the quality of services provided to patients. Early cancer screening is increasingly becoming a part of healthcare services in many countries.
This is the first private hospital in Dubai to offer this innovative early cancer detection device. It is hoped that this will boost cancer diagnosis in the UAE.
According to health professionals, early detection can help to lower the number of deaths caused by cancer as it will enable patients to begin treatment earlier. There is an increasing focus on preventive health care and advanced screening programs in the UAE.
Group CEO of American Hospital Dubai,Sherif Beshara said, “We are extremely pleased to partner with Abbott to usher in a new chapter for cancer diagnostics in the UAE. Early detection is critical to improving cancer care outcomes, and our partnership with Abbott to introduce these advanced detection technologies will help the UAE reach many new milestones in delivering effective cancer care.”
Also Read: UAE Unveils AI Cancer Drug ISM0387: 90 Molecules in 6 Months